Invention Grant
- Patent Title: Double-stranded RNA compounds to CASP2 and uses thereof
- Patent Title (中): 双链RNA化合物到CASP2及其用途
-
Application No.: US14370061Application Date: 2013-01-03
-
Publication No.: US09382542B2Publication Date: 2016-07-05
- Inventor: Shai Erlich , James D. Thompson , Rabia Ozden
- Applicant: QUARK PHARMACEUTICALS, INC.
- Applicant Address: US CA Fremont
- Assignee: Quark Pharmaceuticals, Inc.
- Current Assignee: Quark Pharmaceuticals, Inc.
- Current Assignee Address: US CA Fremont
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2013/020012 WO 20130103
- International Announcement: WO2013/103632 WO 20130711
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
The present disclosure relates to methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, and includes treatment regimens using a double-stranded RNA compound that down-regulates CASP2 expression, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20140371439A1 DOUBLE-STRANDED RNA COMPOUNDS TO CASP2 AND USES THEREOF Public/Granted day:2014-12-18
Information query
IPC分类:
